Answers are grounded in this paper and cite their sources.
The precise detection of biomarkers in complex biofluids remains a significant challenge for electrochemical biosensors, largely due to biofouling and the susceptibility of peptide-based antifouling interfaces to enzymatic degradation. Herein, we report a bilateral proline (P)-rich peptide scaffold, CPPCEKEKEKEKCPPC (Cys-Pro-Pro-Cys-Glu-Lys-Glu-Lys-Glu-Lys-Glu-Lys-Cys-Pro-Pro-Cys), which introduces CPPC motifs at both termini of the antifouling EKEKEKEK sequence to enforce a rigid architecture across the entire antifouling sequence. Molecular dynamics (MD) simulations reveal a fundamental structural distinction: unlike the linear peptide CEKEKEKEK and its simple cyclic-like analogue CEKEKEKEKCboth of which adopt extended, flexible conformationsCPPCEKEKEKEKCPPC retains a cyclic architecture due to the bilateral proline-rich constraint. This intrinsic rigidity confers markedly enhanced resistance to proteolytic degradation and exceptional long-term antifouling stability exceeding 45 days in complex media including serum, saliva, and sweat, substantially outperforming both linear and conventional cyclic-like peptide analogues. As a proof of concept, we constructed an electrochemical aptasensor using CPPCEKEKEKEKCPPC as the antifouling self-assembled monolayer (SAM), enabling direct detection of C-reactive protein (CRP) in undiluted human saliva with a detection limit of 3.31 fg/mL. Importantly, the biosensor demonstrates reliability with commercial ELISA methods in clinical sample analysis. With its high accuracy and capacity for direct detection in complex biofluids, this bilateral constraint strategy provides a broadly applicable platform for the formation of a stable antifouling SAM toward diverse biomedical applications.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: